HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Herold Selected Research

Christian Herold Research Topics

Disease

7Neoplasms (Cancer)
11/2023 - 08/2005
7Chordoma
04/2009 - 12/2004
5Pain (Aches)
10/2023 - 02/2012
4Osteoarthritis
10/2023 - 08/2017
4Burns
10/2016 - 10/2010
3Wounds and Injuries (Trauma)
12/2011 - 10/2010
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2020 - 07/2019
2Chronic Pain
01/2018 - 02/2012
1Interstitial Lung Diseases (Interstitial Lung Disease)
02/2022
1Weight Loss (Weight Reduction)
04/2021
1Bronchogenic Carcinoma
08/2020
1Lipedema
04/2019
1Hepatitis C
01/2018
1Liver Diseases (Liver Disease)
01/2018
1Antisynthetase syndrome
08/2016
1Non-alcoholic Fatty Liver Disease
06/2014
1Liver Cirrhosis (Hepatic Cirrhosis)
06/2014
1Fibrosis (Cirrhosis)
06/2014
1Fatty Liver
06/2014
1Peripheral Arterial Occlusive Disease 1
07/2012
1Diabetes Mellitus
07/2012
1Photosensitivity Disorders (Photodermatitis)
02/2012
1Staphylococcal Infections
12/2011
1Wound Infection (Wound Infections)
12/2011
1Infections
12/2011
1Ischemia
11/2011
1Reperfusion Injury
11/2011
1Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide)
08/2011
1Venous Thrombosis (Deep-Vein Thrombosis)
07/2011
1Thrombocytopenia (Thrombopenia)
07/2011
1Soft Tissue Injuries (Soft Tissue Injury)
10/2010
1Soft Tissue Infections
10/2010
1Syndactyly (Polysyndactyly)
10/2010
1Pulmonary Embolism
06/2009
1Pulmonary Edema
05/2006
1Edema (Dropsy)
05/2006

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
11/2023 - 07/2019
3PlasticsIBA
04/2019 - 10/2010
3CAM 5.2 antigenIBA
04/2009 - 01/2008
3Peptide Hydrolases (Proteases)FDA Link
02/2008 - 12/2004
2Proteins (Proteins, Gene)FDA Link
02/2022 - 09/2005
2LigandsIBA
07/2019 - 04/2009
2gadolinium ethoxybenzyl DTPAFDA Link
01/2018 - 06/2014
2Ion Channels (Ion Channel)IBA
01/2018 - 02/2012
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2009 - 01/2008
2Cathepsin BIBA
02/2008 - 12/2004
2Plasminogen Activators (Plasminogen Activator)IBA
02/2008 - 12/2004
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2008 - 12/2004
2Matrix Metalloproteinases (MMPs)IBA
02/2008 - 12/2004
2Indicators and Reagents (Reagents)IBA
09/2005 - 08/2005
1RadiopharmaceuticalsIBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
07/2019
1Ammonium CompoundsIBA
01/2018
1azobenzeneIBA
01/2018
1InterferonsIBA
01/2018
1A 17 (A-17)IBA
10/2016
1BiobraneIBA
10/2016
1Ligases (Synthetase)IBA
08/2016
1AntibodiesIBA
08/2016
1Transfer RNA (tRNA)IBA
08/2016
1Syntex adjuvant formulationIBA
06/2014
1Local AnestheticsIBA
02/2012
1Carbon MonoxideIBA
08/2011
1Heparin (Liquaemin)FDA LinkGeneric
07/2011
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
07/2011
1iodixanol (Visipaque)FDA Link
06/2009
1iomeprolIBA
06/2009
1Keratins (Keratin)IBA
04/2009
1Plasminogen InactivatorsIBA
02/2008
1Contrast MediaIBA
05/2006
1Oleic Acid (Oleate)IBA
05/2006
1Cyclin D1IBA
09/2005
1Cyclin-Dependent Kinase Inhibitor p16IBA
09/2005
1CollagenIBA
01/2005

Therapy/Procedure

7Therapeutics
11/2023 - 07/2012
5Transplantation
10/2023 - 08/2011
3Aftercare (After-Treatment)
10/2023 - 08/2017
2Immunotherapy
08/2020 - 01/2016
2Surgical Amputation (Amputations)
12/2011 - 10/2010
1Operative Surgical Procedures
01/2022
1Lipectomy (Liposuction)
04/2019
1Rejuvenation
07/2012
1Knee Replacement Arthroplasty (Total Knee Replacement)
12/2011
1Arthrodesis
12/2011
1Free Tissue Flaps
11/2011
1Tourniquets
11/2011
1Contraindications
08/2011
1Organ Transplantation
08/2011
1Cardiopulmonary Resuscitation (CPR)
08/2011
1Critical Care (Surgical Intensive Care)
07/2011